Articles tagged "Malignancy"

2020 American Transplant Congress
Multimodal Strategy for Hepatocellular Carcinoma in the Elderly: To Transplant or Not to Transplant
M. Najjar¹, O. Perez¹, J. Zou¹, S. Sun¹, K. Bruestle¹, P. Jiang¹, E. Verna¹, E. Zheng¹, Y. Saenger¹, A. Mathur¹, A. Griesemer¹, B. Samstein², T. Kato¹, K. Halazun², J. Emond¹
¹Columbia University Irving Medical Center, New York, NY, ²Weill Cornell Medicine, New York, NY
*Purpose: Liver transplantation LT for HCC is curative but entails increased risk and is limited by organ scarcity. Alternative approaches such as locoregional therapy (LRT)…
2020 American Transplant Congress
Comparative Analysis of Risk Factors and Outcomes in Kidney Transplant Recipients with Lung Cancer and Those with No Malignancy: UNOS Data Set
H. Patel¹, V. Nissaisorakarn², E. Sula Karrecci¹, N. Agrawal¹, F. Cardarelli¹
¹Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ²Department of Internal Medicine, Metrowest Medical Center, Boston, MA
*Purpose: Transplant recipients are at increased risk for malignancy. Patients who develop cancer after transplant have worse outcomes, especially those with lung cancer. Transplant-related risk…
2020 American Transplant Congress
Incident Malignancies among Post Kidney-Transplant Patients by Type of Induction Immunosuppression and by Age
L. Wang, J. Motter, S. Bae, D. Segev, M. McAdams DeMarco
Johns Hopkins University, Baltimore, MD
*Purpose: Adult kidney-transplant (KT) recipients have a differential risk of malignancies based on their induction immunosuppression (IS) therapy. However, older recipients are more likely to…
2020 American Transplant Congress
Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma
M. Najjar¹, J. Makkar¹, S. Sun¹, J. Zou¹, O. Perez¹, P. Jiang¹, Y. Saenger¹, E. Zheng¹, E. Verna¹, A. Mathur¹, A. Griesemer¹, K. Halazun², B. Samstein², T. Kato¹, J. Emond¹
¹Columbia University Medical Center/New-York Presbyterian, New York, NY, ²Weill Cornell Medicine, New York, NY
*Purpose: Combined hepatocholangiocarcinomas (HCC-CCA) are rare tumors with both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) differentiations. They are usually associated with a worse prognosis after…
2020 American Transplant Congress
Kidney Transplantation after Multiple Myeloma: The Last 2 Decades
V. Nair, K. Jhaveri, M. Abate
Medicine, Northwell Health, Manhasset, NY
*Purpose: Due to recent advances, patients with a history of multiple myeloma (MM) and ESKD are more frequently offered kidney transplantation (Ktx). Existing literature does…
2020 American Transplant Congress
Neoadjuvant Gem/Cis Followed by Transarterial Radioembolization for Locally Advanced iCCA with Intent for Curative Resection
T. Baker, J. Fung, D. Disabato, A. Pillai, O. Ahmed, A. Liao
Transplantation Institute, The University of Chicago, Chicago, IL
*Purpose: Locally advanced intrahepatic cholangiocarcinoma (LAiCCA) has a traditionally poor prognosis with few curative surgical options and a high incidence of postop recurrence. The intent…
2020 American Transplant Congress
A Three-Decade Analysis of Pancreatic Adenocarcinoma Following Liver Transplantation
O. Y. Mousa¹, J. E. Corral², K. Wijarnpreecha², R. Shah³, V. S. Louwagie⁴, M. J. Bartel⁵, B. Brahmbhatt²
¹Mayo Clinic, Rochester, MN, ²Mayo Clinic, Jacksonville, FL, ³Emory University, Atlanta, GA, ⁴Mayo Clinic Health System, Mankato, MN, ⁵Fox Chase Cancer Center, Philadelphia, PA
*Purpose: Liver transplant (LT) recipients are at risk of serious long term complications, including a higher risk of de novo malignancies compared to the general…
2020 American Transplant Congress
Long-Term Liver Transplant Outcomes: A Single Center Cohort Study
S. A. Mao, K. P. Croome, I. J. Galler, C. B. Taner
Mayo Clinic Florida, Jacksonville, FL
*Purpose: This single center study reviews long-term outcomes of liver transplantation identifying morbidity differences between post-transplant liver patients surviving greater than five years versus those…
2020 American Transplant Congress
Functional Changes in Metabolic and Malignancy Associated Bacterial Genes in the Post Transplant Intestinal Microbiome
M. Bhat¹, S. Sivaraj¹, E. Pasini¹, J. Copeland², J. Allard³, A. Humar¹
¹Multi-Organ Transplant, UHN, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³UHN, Toronto, ON, Canada
*Purpose: Long-term survival of liver transplant (LT) recipients is affected by metabolic and malignant complications. The aim of our study was to examine changes in…
2020 American Transplant Congress
Contralateral Upper Tracturothelial Carcinoma after Primary Radical Nephroureterectomy in Kidney Transplant Patients
Z. Wang, J. Lin, Y. Zhu, Y. Guo, Y. Tian
Capital Medical University, Beijing, China
*Purpose: The purpose of the present study was to evaluate the incidence and risk factors of contralateral upper tract urothelial carcinoma (UTUC) after primary radical…

1
2
3
…
16
Next Page »